Thus, the study’s findings suggest that inhibiting GSTA4 could disrupt melanoma cells’ defense mechanisms, rendering them more susceptible to immune-mediated destruction and possibly curbing their metastatic capabilities. The gene discussed is GSTA4; the disease is melanoma.